Galocitabine
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111641This classification denotes a pyrimidine antagonist with the molecular formula C19H22FN3O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X9788XI79O, chemically known as 5-deoxy-5-fluoro-n-(3,4,5-trimethoxybenzoyl)cytidine but generally known as galocitabine, which bears US NIH Compound Identifier 65950. European Medicines Agency schedules Galocitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07875MIG. The term GALOCITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). GALOCITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule galocitabine under HS 29349990 and SITC 51579. As of Q4 2014, GALOCITABINE remains the US FDA Preferred Term for this commodity. Galocitabine bears US NLM identifiers UMLS ID C0084382 and NCI Concept Code C73254. SMILES: FC1CN(C2OC(C(O)C2O)C)C(=O)NC1NC(=O)C1CC(OC)C(OC)C(OC)C1.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.